Shelly Seward

1.2k total citations
34 papers, 898 citations indexed

About

Shelly Seward is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Shelly Seward has authored 34 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Reproductive Medicine and 7 papers in Molecular Biology. Recurrent topics in Shelly Seward's work include Ovarian cancer diagnosis and treatment (15 papers), Endometrial and Cervical Cancer Treatments (6 papers) and HER2/EGFR in Cancer Research (5 papers). Shelly Seward is often cited by papers focused on Ovarian cancer diagnosis and treatment (15 papers), Endometrial and Cervical Cancer Treatments (6 papers) and HER2/EGFR in Cancer Research (5 papers). Shelly Seward collaborates with scholars based in United States, Canada and Germany. Shelly Seward's co-authors include Kathleen N. Moore, Sanjeev Kumar, Robert Morris, Assaad Semaan, Aamer Qazi, Ramesh B. Batchu, Raymond P. Perez, Adnan Munkarah, Michael J. Birrer and Ursula A. Matulonis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Molecular Cancer.

In The Last Decade

Shelly Seward

32 papers receiving 881 citations

Peers

Countries citing papers authored by Shelly Seward

Since Specialization

Citations

This map shows the geographic impact of Shelly Seward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelly Seward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelly Seward more than expected).

Fields of papers citing papers by Shelly Seward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelly Seward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelly Seward. The network helps show where Shelly Seward may publish in the future.

Co-authorship network of co-authors of Shelly Seward

This figure shows the co-authorship network connecting the top 25 collaborators of Shelly Seward. A scholar is included among the top collaborators of Shelly Seward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelly Seward. Shelly Seward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reactive angioendotheliomatosis as a side effect of long-acting injectable insulin use 2025 ·Dermatology Online Journal ·(unknown), Shelly Seward, Terrence M. Katona, Sahand Rahnama‐Moghadam	0
2	Antibody Drug Conjugates in the Treatment of Epithelial Ovarian Cancer 2018 ·Hematology/Oncology Clinics of North America ·Debra L. Richardson, Shelly Seward, Kathleen N. Moore	6
3	Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer 2017 ·Gynecologic Oncology ·İsmail Mert, Jasdeep Chhina, Ghassan Allo, Jing Dai, Shelly Seward, Mark Carey, (unknown), Shailendra Giri, Ramandeep Rattan, Adnan Munkarah	20
4	Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine 2017 ·Gynecologic Oncology ·Lainie P. Martin, Jason Konner, Kathleen N. Moore, Shelly Seward, Ursula A. Matulonis, Raymond P. Perez, Ying Su, Anna Berkenblit, Rodrigo Ruiz-Soto, Michael J. Birrer	104
5	Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis 2016 ·Gynecologic Oncology ·Kathleen N. Moore, James Java, (unknown), Peter G. Rose, Rachelle Lanciano, Paul DiSilvestro, J.T. Thigpen, Yi-Chun Lee, Krishnansu S. Tewari, Junzo Chino, Shelly Seward, David S. Miller, Ritu Salani, David H. Moore, Frederick B. Stehman	31
6	Primary debulking surgery and neoadjuvant chemotherapy in the treatment of advanced epithelial ovarian carcinoma 2015 ·Cancer and Metastasis Reviews ·Shelly Seward, Ira Winer	12
7	Endometrial cancer in morbidly obese women: Do racial disparities affect surgical or survival outcomes? 2014 ·Gynecologic Oncology ·Michele L. Coté, Julie J. Ruterbusch, (unknown), Subhayu Bandyopadhyay, (unknown), Eman Abdulfatah, Shelly Seward, Robert Morris, Rouba Ali‐Fehmi	10
8	EZH2-shRNA–mediated upregulation of p21waf1/cip1 and its transcriptional enhancers with concomitant downmodulation of mutant p53 in pancreatic ductal adenocarcinoma 2013 ·Surgery ·Ramesh B. Batchu, Aamer Qazi, (unknown), Assaad Semaan, Shelly Seward, (unknown), (unknown), David L. Bouwman, Donald W. Weaver, Scott A. Gruber	6
9	EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21waf1/cip1 and by inhibiting mutant p53 2013 ·Cancer Letters ·Shelly Seward, Assaad Semaan, Aamer Qazi, (unknown), (unknown), (unknown), Sanjeev Kumar, David Cameron, Seema Sethi, Rouba Ali‐Fehmi, Robert Morris, David L. Bouwman, Adnan Munkarah, Donald W. Weaver, Scott A. Gruber, Ramesh B. Batchu	25
10	Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101 2012 ·Surgery ·Aamer Qazi, (unknown), Assaad Semaan, Shelly Seward, (unknown), (unknown), Seema Sethi, Rouba Ali‐Fehmi, Philip A. Philip, David L. Bouwman, Donald W. Weaver, Scott A. Gruber, Ramesh B. Batchu	26
11	Prognostic Impact of Laterality in Malignant Ovarian Germ Cell Tumors 2011 ·International Journal of Gynecological Cancer ·Haider Mahdi, Sanjeev Kumar, Shelly Seward, Assaad Semaan, Ramesh B. Batchu, David Lockhart, Hisham K. Tamimi, Adnan Munkarah	23
12	Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: An epidemiological analysis 2011 ·Gynecologic Oncology ·(unknown), Sanjeev Kumar, Shelly Seward, Assaad Semaan, Charles A. Schiffer, Adnan Munkarah, Robert Morris	18
13	MicroRNA-101 Inhibits Growth of Epithelial Ovarian Cancer by Relieving Chromatin-Mediated Transcriptional Repression of p21waf1/cip1 2011 ·Pharmaceutical Research ·Assaad Semaan, Aamer Qazi, Shelly Seward, (unknown), Christopher S. Bryant, Sanjeev Kumar, Robert Morris, Christopher P. Steffes, David L. Bouwman, Adnan Munkarah, Donald W. Weaver, Scott A. Gruber, Ramesh B. Batchu	52
14	Prognostic impact of lymphadenectomy in clinically early-stage ovarian malignant germ cell tumor 2011 ·Gynecologic Oncology ·Haider Mahdi, Rabbie K. Hanna, Shelly Seward, Ron E. Swensen, Hisham K. Tamimi, Robert T. Morris, (unknown)	1
15	The prognostic significance of the triple negative phenotype in endometrial cancer 2010 ·Gynecologic Oncology ·(unknown), Carl Morrison, Debra L. Richardson, Shelly Seward, David M. O’Malley, Larry J. Copeland, Jeffrey M. Fowler, David E. Cohn	14
16	Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells 2010 ·Molecular Cancer ·Christopher S. Bryant, Sanjeev Kumar, (unknown), Jay P. Shah, Jagannath Pal, (unknown), Shelly Seward, Aamer Qazi, Robert Morris, Assaad Semaan, Masood A. Shammas, Christopher P. Steffes, (unknown), Madhu Prasad, Donald W. Weaver, Ramesh B. Batchu	58
17	Expression of GLUT-1 in epithelial ovarian carcinoma: Correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction 2010 ·Gynecologic Oncology ·Assaad Semaan, Adnan Munkarah, Haitham Arabi, Subhayu Bandyopadhyay, Shelly Seward, Sanjeev Kumar, Aamer Qazi, (unknown), Robert Morris, Rouba Ali‐Fehmi	55
18	Radiation-Associated Endometrial Cancer 2009 ·Obstetrics and Gynecology ·Sanjeev Kumar, Jay P. Shah, Christopher S. Bryant, Shelly Seward, Rouba Ali‐Fehmi, Robert Morris, John M. Malone	14
19	Metastatic Squamous Cell Carcinoma of the Vulva to the Lung Confirmed With Allelotyping 2009 ·International Journal of Gynecological Pathology ·Shelly Seward, Debra L. Richardson, Marino E. Leon, Weiqiang Zhao, David E. Cohn, Charles L. Hitchcock	5
20	Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells 2009 ·Molecular Cancer ·Sanjeev Kumar, Christopher S. Bryant, (unknown), Aamer Qazi, Shelly Seward, Jagannath Pal, Christopher P. Steffes, Donald W. Weaver, Robert Morris, John M. Malone, Masood A. Shammas, Madhu Prasad, Ramesh B. Batchu	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact